Ajanta Pharma Q4 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
2,707.00
58.15 (2.20%)
58.15 (2.20%)Volume8.19 K
Updated: Tue 15 Jul, 2025 | 15:29:56
NSE
2,697.7051.30 (1.94%)
51.30 (1.94%)Volume3.92 L
Updated: Tue 15 Jul, 2025 | 15:44:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹1,170.41 Cr.(11.04%)
- Operating Profit₹257.37 Cr.(5.45%)
- Profit After Tax₹225.26 Cr.(11.12%)
- Operating Margin21.99%(-5.03%)
Note: Comparison is on YoY basis
Quarterly - Ajanta Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 913.04 | 861.27 | 6.01% | 810.01 | 12.72% |
| Depreciation/ Amortization | 39.78 | 35.97 | 10.59% | 34.25 | 16.15% |
| Operating Income | 257.37 | 284.86 | -9.65% | 244.07 | 5.45% |
| Net Income | 225.26 | 232.88 | -3.27% | 202.72 | 11.12% |
| Net Income Before Taxes | 269.41 | 307.39 | -12.36% | 278.04 | -3.10% |
| Other Operating Expenses Total | 310.06 | 302.32 | 2.56% | 277.87 | 11.58% |
| Total Revenue | 1,170.41 | 1,146.13 | 2.12% | 1,054.08 | 11.04% |
| Selling/ General/ Admin Expenses Total | 279.78 | 265.17 | 5.51% | 233.51 | 19.81% |
| Diluted Normalized EPS | 18.04 | 18.59 | -2.98% | 16.09 | 12.09% |